FAQ - frequently asked questions

1. What is the UTI-Diag project?

The UTI-Diag project is an initiative funded by the European Union, aimed at improving the diagnosis and management of urinary tract infections through innovative diagnostic tools. The project focuses particularly on resource-limited areas, such as Sub-Saharan Africa, where urinary tract infections and antimicrobial resistance (AMR) are major public health issues.

2. Who are the partners of the UTI-Diag project?

The project is led by a consortium of 11 international organizations, including academic institutions, research centers, technology companies, and public health organizations, such as:

Karolinska Institutet (KI) – Sweden
Institut Pasteur de Dakar (IPD) – Senegal
Centre Pasteur of Cameroon (CPC) – Cameroon
Market Access Africa MAA Healthcare Company (MAA) – South Africa
Aviro Med Design Pty Ltd Health (Aviro) – South Africa
Teesside University (TU) – UK
Albert-Ludwigs-Universität University of Freiburg (UFR) – Germany
Global Access Diagnostics (GADx) – UK
Capitainer AB (CAP) – Sweden
Aidian Oy (AIDIAN) – Finland
Pasteur Network (PN) – France

3. Who benefits from the results of the UTI-Diag project?

The primary target groups of the project are:

Healthcare professionals: Doctors, biologists, pharmacists.
Institutions, industry partners, and donors: Universities, research laboratories, biotechnology companies, etc.
The general public: Patients, patient associations.
The media: Local, regional, and international media.

4. How can I follow the progress of the project?

You can track the progress of the project by visiting our website, reading our publications, and subscribing to our newsletter. We will also share updates regularly on our social media pages like LinkedIn, Twitter and youtube.

5. Why is the diagnosis of urinary tract infections so important?

Accurate and timely diagnosis is crucial for combating urinary tract infections, especially by reducing inappropriate antibiotic use. This helps minimize the risk of antimicrobial resistance (AMR) and ensures effective patient care.

6. How can I support the UTI-Diag project?

You can support the project by subscribing to our newsletter, sharing our information via your social networks, or supporting the project’s awareness-raising and dissemination initiatives.